S&P 500   3,961.65 (+0.33%)
DOW   32,190.48 (+0.27%)
QQQ   310.06 (+0.10%)
AAPL   159.92 (+0.62%)
MSFT   279.01 (+0.49%)
META   205.54 (+0.62%)
GOOGL   105.05 (-0.52%)
AMZN   98.11 (-0.61%)
TSLA   190.19 (-1.06%)
NVDA   266.45 (-2.01%)
NIO   9.03 (-2.59%)
BABA   86.70 (+0.21%)
AMD   97.79 (-2.48%)
T   18.59 (+0.70%)
F   11.49 (+0.61%)
MU   60.72 (-1.01%)
CGC   1.92 (+0.52%)
GE   90.86 (-0.80%)
DIS   94.08 (-1.83%)
AMC   4.50 (+0.67%)
PFE   40.38 (+0.50%)
PYPL   73.54 (+1.35%)
NFLX   327.63 (+2.27%)
S&P 500   3,961.65 (+0.33%)
DOW   32,190.48 (+0.27%)
QQQ   310.06 (+0.10%)
AAPL   159.92 (+0.62%)
MSFT   279.01 (+0.49%)
META   205.54 (+0.62%)
GOOGL   105.05 (-0.52%)
AMZN   98.11 (-0.61%)
TSLA   190.19 (-1.06%)
NVDA   266.45 (-2.01%)
NIO   9.03 (-2.59%)
BABA   86.70 (+0.21%)
AMD   97.79 (-2.48%)
T   18.59 (+0.70%)
F   11.49 (+0.61%)
MU   60.72 (-1.01%)
CGC   1.92 (+0.52%)
GE   90.86 (-0.80%)
DIS   94.08 (-1.83%)
AMC   4.50 (+0.67%)
PFE   40.38 (+0.50%)
PYPL   73.54 (+1.35%)
NFLX   327.63 (+2.27%)
S&P 500   3,961.65 (+0.33%)
DOW   32,190.48 (+0.27%)
QQQ   310.06 (+0.10%)
AAPL   159.92 (+0.62%)
MSFT   279.01 (+0.49%)
META   205.54 (+0.62%)
GOOGL   105.05 (-0.52%)
AMZN   98.11 (-0.61%)
TSLA   190.19 (-1.06%)
NVDA   266.45 (-2.01%)
NIO   9.03 (-2.59%)
BABA   86.70 (+0.21%)
AMD   97.79 (-2.48%)
T   18.59 (+0.70%)
F   11.49 (+0.61%)
MU   60.72 (-1.01%)
CGC   1.92 (+0.52%)
GE   90.86 (-0.80%)
DIS   94.08 (-1.83%)
AMC   4.50 (+0.67%)
PFE   40.38 (+0.50%)
PYPL   73.54 (+1.35%)
NFLX   327.63 (+2.27%)
S&P 500   3,961.65 (+0.33%)
DOW   32,190.48 (+0.27%)
QQQ   310.06 (+0.10%)
AAPL   159.92 (+0.62%)
MSFT   279.01 (+0.49%)
META   205.54 (+0.62%)
GOOGL   105.05 (-0.52%)
AMZN   98.11 (-0.61%)
TSLA   190.19 (-1.06%)
NVDA   266.45 (-2.01%)
NIO   9.03 (-2.59%)
BABA   86.70 (+0.21%)
AMD   97.79 (-2.48%)
T   18.59 (+0.70%)
F   11.49 (+0.61%)
MU   60.72 (-1.01%)
CGC   1.92 (+0.52%)
GE   90.86 (-0.80%)
DIS   94.08 (-1.83%)
AMC   4.50 (+0.67%)
PFE   40.38 (+0.50%)
PYPL   73.54 (+1.35%)
NFLX   327.63 (+2.27%)
NASDAQ:LFCR

Lifecore Biomedical - LFCR News Today

$3.02
-0.02 (-0.66%)
(As of 03/24/2023 02:50 PM ET)
Add
Compare
Today's Range
$2.76
▼
$3.05
50-Day Range
$1.67
▼
$7.25
52-Week Range
$1.52
▼
$11.95
Volume
373,412 shs
Average Volume
866,072 shs
Market Capitalization
$91.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50
Get Lifecore Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter.


LFCR Media Mentions By Week

LFCR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LFCR
News Sentiment
▼
-0.12

0.36
▲
Average
Medical
News Sentiment

LFCR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LFCR Articles
This Week
▼
18

2
▲
LFCR Articles
Average Week

SourceHeadline
MarketBeat logoLifecore Biomedical, Inc. Forecasted to Post Q3 2023 Earnings of ($0.13) Per Share (NASDAQ:LFCR)
americanbankingnews.com - March 24 at 2:00 AM
MarketBeat logoBarrington Research Trims Lifecore Biomedical (NASDAQ:LFCR) Target Price to $8.00
americanbankingnews.com - March 23 at 4:42 AM
MarketBeat logoLifecore Biomedical, Inc. (NASDAQ:LFCR) Forecasted to Earn Q3 2024 Earnings of $0.07 Per Share
americanbankingnews.com - March 22 at 2:44 AM
markets.businessinsider.com logoAnalyst Ratings for Lifecore Biomedical
markets.businessinsider.com - March 21 at 2:52 PM
msn.com logoLifecore Biomedical, Inc. - Common Stock's Return On Capital Employed Insights
msn.com - March 20 at 12:56 PM
MarketBeat logoLifecore Biomedical (NASDAQ:LFCR) Rating Lowered to Equal Weight at Stephens
americanbankingnews.com - March 20 at 7:40 AM
MarketBeat logoStephens Reaffirms Overweight Rating for Lifecore Biomedical (NASDAQ:LFCR)
americanbankingnews.com - March 20 at 4:58 AM
finance.yahoo.com logoQ2 2023 Lifecore Biomedical Inc Earnings Call
finance.yahoo.com - March 18 at 2:07 AM
seekingalpha.com logoLifecore craters ~60% on 'substantial doubt' as going concern; explores options amid Q2 miss
seekingalpha.com - March 17 at 4:06 PM
msn.com logoLifecore Biomedical Non-GAAP EPS of -$0.24 misses by $0.20, revenue of $38.8M misses by $9.61M
msn.com - March 16 at 5:52 PM
finance.yahoo.com logoLifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
finance.yahoo.com - March 16 at 5:52 PM
finance.yahoo.com logoLifecore Biomedical Announces Intent to Explore Strategic Alternatives
finance.yahoo.com - March 16 at 5:52 PM
finance.yahoo.com logoLifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
finance.yahoo.com - March 16 at 5:52 PM
MarketBeat logoCritical Review: Lifecore Biomedical (LFCR) vs. Its Competitors
americanbankingnews.com - March 14 at 3:38 AM
finance.yahoo.com logoShould You Invest in Lifecore Biomedical (LFCR)?
finance.yahoo.com - February 16 at 10:34 AM
finance.yahoo.com logoLifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
finance.yahoo.com - February 7 at 6:08 PM
msn.com logoLifecore Biomedical to restate financials after finding errors
msn.com - February 2 at 8:29 PM
seekingalpha.com logoLFCR Lifecore Biomedical, Inc.
seekingalpha.com - January 28 at 12:29 AM
finance.yahoo.com logoShould You Hold Lifecore Biomedical (LFCR)?
finance.yahoo.com - January 12 at 9:18 AM
finance.yahoo.com logoLifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
finance.yahoo.com - January 11 at 6:52 PM
finance.yahoo.com logoLifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
finance.yahoo.com - January 9 at 5:31 PM
finance.yahoo.com logoInvestors in Lifecore Biomedical (NASDAQ:LFCR) have unfortunately lost 47% over the last five years
finance.yahoo.com - December 28 at 2:33 PM
finance.yahoo.com logoLifecore Biomedical, Inc. (NASDAQ:LFCR): Are Analysts Optimistic?
finance.yahoo.com - December 8 at 6:41 AM
msn.com logo$5 Million Bet On Lifecore Biomedical? Check Out These 4 Stocks Insiders Are Buying
msn.com - November 30 at 8:30 AM
Get Lifecore Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:LFCR) was last updated on 3/24/2023 by MarketBeat.com Staff